A detailed history of Act Two Investors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Act Two Investors LLC holds 8,449 shares of LLY stock, worth $8.63 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
8,449
Holding current value
$8.63 Million
% of portfolio
1.15%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$625.65 - $812.69 $5.29 Million - $6.87 Million
8,449 New
8,449 $6.45 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Act Two Investors LLC Portfolio

Follow Act Two Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Two Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Two Investors LLC with notifications on news.